Observational study / 2005
Yersinia enterocolitica O:3 infection was linked to a higher prevalence of inflammatory bowel disease.
Between 1990 and 1997, antibody responses against Y. enterocolitica were evaluated in 1588 patients by tube agglutination. Forty-one patients with infection (titer = 320) and 1041 controls without antibody response were followed for 6-13 years until 2003. Overall, IBD occurred in 8 of 41 patients in the infection group (5 with ulcerative colitis, 3 with Crohn's disease) compared to 42 of 1041 in the control group (32 UC, 10 CD), representing a statistically significant difference (p = 0.00035). Significant differences were also found when examining ulcerative colitis (p = 0.006) and Crohn's disease (p < 0.015) separately.
Shows an association, not proof of cause and effect.
- Study type
- Cohort study
- Who was studied
- 41 patients with Y. enterocolitica infection and 1041 controls without antibody response
- What was measured
- Prevalence of inflammatory bowel disease (ulcerative colitis and Crohn's disease) over 6-13 years
THE PAPER
Inflammatory bowel disease associated with Yersinia enterocolitica O:3 infection.
Saebo A, Vik E, Lange OJ, Matuszkiewicz L. Eur J Intern Med, 2005.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.